Response to Matters Arising about the Etiology of Ventilator-associated Pneumonia in the European POS-VAP Cohort
Ecraid POS-VAP Study Group responds to scientific commentary in Critical Care.
Following publication of the European cohort study on the epidemiology of ventilator-associated pneumonia (VAP), authors have published a formal response to correspondence regarding pathogen distribution. The reply addresses queries surrounding the prominent ranking of Staphylococcus aureus (S. aureus) by contextualising the cohort's specific clinical demographics and early-onset patient profiles.
This constructive dialogue highlights the ongoing importance of tracking contemporary microbiological variations across diverse clinical networks to support accurate global antibiotic stewardship guidelines.
- Original manuscript published 14 March 2026.
- Letter to Matters Arising published 9 April 2026.
- Response to Matters Arising published 18 June 2026.